POST Facilitation for Community Dwelling Older Adults (POST-RCT)
NCT ID: NCT04070183
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
389 participants
INTERVENTIONAL
2020-05-11
2025-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile App Psychological Interventions for Family Dementia Caregivers
NCT05253443
Indiana University Dementia Screening Trial
NCT01699503
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
NCT05733520
Five Session Unified Protocol for Older Adults With Emotional Distress and Reduced Mobility
NCT04837521
Dyadic Tailored Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge
NCT07081750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
POLST affects delivery of medical interventions and improved concordance between patient preferences and care received.
Our specific aims are:
1. To test the effect of high quality POLST Facilitation delivered in the home compared to attention control on:
a.discordance between preferences for treatment and treatments received in the subsequent 12 months (primary outcome).
2. To test the effect of POLST Facilitation on intermediate outcomes including:
1. The proportion of patients with a completed POLST form in the electronic medical record within 3 months of POLST Facilitation
2. Decision quality regarding ACP as measured by the Decisional Conflict Scale, the advance care planning (ACP) Engagement Survey,and the POLST knowledge survey
3. To test the effect of a POLST Facilitation on secondary outcomes of cost and end-of-life care including:
1. Receipt of life-sustaining interventions or hospice within the 30 days prior to death, for patients who die during the year after POLST Facilitation
2. The psychological well-being (anxiety, depression,and post traumatic stress) of surrogate decision makers after the patient's death
3. The cost effectiveness of POLST Facilitation for the prevention of ICU admissions and hospitalizations
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention Control (Home Safety Evaluation)
A nurse will complete a home visit with the patient and their surrogate decision maker or other family member (if they've designated one), in which he or she will provide suggestions on how to improve the safety of the patient's home.
Home Safety Evaluation
Nurse evaluation and education on how to improve safety at home for community dwelling older adults (examples of education and evaluation includes fall risks, fire and carbon monoxide (CO) detectors, transferring safety (e.g. in and out of the tub, bed, etc.) and others.
Intervention (POST Facilitation)
A nurse will complete a home visit with the patient and their surrogate decision maker or other family (if they've designated one), in which he or she will provide education about the POST form. The POST facilitators will be nurses trained using the Respecting Choices Advanced Steps model.
POST Facilitation
Advanced steps is initiated as a component of quality end-of-life care for frail elders and those whose death in the next 12 months would not be unexpected. The AS planning conversation is focused on goals of care to make timely, proactive, and specific end-of-life decisions. Ideally, these decisions are converted into medical orders that can be followed throughout the continuum of care. The Physician Orders for Life-Sustaining Treatment (POLST) program is the nationally recognized model for this stage of planning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
POST Facilitation
Advanced steps is initiated as a component of quality end-of-life care for frail elders and those whose death in the next 12 months would not be unexpected. The AS planning conversation is focused on goals of care to make timely, proactive, and specific end-of-life decisions. Ideally, these decisions are converted into medical orders that can be followed throughout the continuum of care. The Physician Orders for Life-Sustaining Treatment (POLST) program is the nationally recognized model for this stage of planning.
Home Safety Evaluation
Nurse evaluation and education on how to improve safety at home for community dwelling older adults (examples of education and evaluation includes fall risks, fire and carbon monoxide (CO) detectors, transferring safety (e.g. in and out of the tub, bed, etc.) and others.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 65 or older
* have decision making capacity OR a qualified surrogate decision maker
* must meet one of the following index scores:
* Gagne Mortality Index score of 7 or greater (30% mortality risk)
* Medicare Criteria for Hospice Admission: Functional Assessment Staging Tool (FAST) Index (Advanced Alzheimer's disease and related dementia) 7c or higher plus one or more comorbid conditions.
* Seattle Heart Failure Model (congestive heart failure): score conferring a one-year mortality risk of 30% or greater
* Eastern Cooperative Oncology Group (ECOG) performance status (metastatic cancer): Patients with an impaired performance score (greater than zero)
* Liu Comorbidity Index (End Stage Renal Disease): Patients with a score of 10 or greater
* blood results (B), age (A), respiratory variables (airflow obstruction, exacerbations, smoking) (R) and comorbidities (C) (BARC) Index for chronic obstructive pulmonary disease (COPD): high risk group
* Model for End Stage Liver Disease (MELD) Index
* must be able to pass consent verification
* must not be enrolled in hospice
* must not have an acute illness
* must give patient's provider opportunity to review the "surprise question" (e.g. would you be surprised if the patient died in the next year) to confirm anticipated mortality within the next year (14 days to respond)
* must not have a POST form on file.
Exclusion Criteria
* patients who are already enrolled in hospice
* patients or surrogates who cannot pass consent verification
* patients or surrogates who do not speak English
* patients with a POST form on file
* patients who are not community-dwelling
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
National Institutes of Health (NIH)
NIH
Regenstrief Institute, Inc.
OTHER
Indiana University Health
OTHER
Eskenazi Health
OTHER
Respecting Choices
UNKNOWN
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexia M. Torke
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexia M Torke, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Regenstrief Institute, Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eskenazi Health
Indianapolis, Indiana, United States
IU Health Methodist Hospital
Indianapolis, Indiana, United States
IU Health University Hospital
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Torke AM, Hickman S, Wocial L, Monahan PO, Burke ES, Slaven J, Ziemba K, Montgomery C, Koch S, Cavanaugh M, Fox Ludden E. Planning Ahead: protocol for a randomised trial of advance care planning for community dwelling older adults at increased mortality risk. BMJ Open. 2025 May 24;15(5):e102186. doi: 10.1136/bmjopen-2025-102186.
Related Links
Access external resources that provide additional context or updates about the study.
POLST Facilitation in Complex Care Management: A Feasibility Study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1905850231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.